Relapses in the Guillain–Barré syndrome after treatment with intravenous immune globulin or plasma exchange
✍ Scribed by J.G. Romano; F.T. Rotta; P. Potter; V. Rosenfeld; R. Santibanez; B. Rocha; W.G. Bradley
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 72 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
✦ Synopsis
To clarify the question of whether Guillain-Barre ´syndrome (GBS) patients treated with intravenous immune globulin (IVIG) relapse at a higher frequency than those treated with plasma exchange (PE), 54 patients with GBS were studied retrospectively. A higher frequency of relapses was noted in the PE-treated patients than in those receiving IVIG. The presence of an associated medical condition correlated with an increased risk of relapses, while earlier onset of treatment resulted in a decrease of relapses of GBS. This study found no support for prior suggestions of increased relapses in patients with GBS treated with IVIG as opposed to those treated with PE.